Literature DB >> 20010862

Melanoma molecular subtypes: unifying and paradoxical results.

Nancy E Thomas1, Peter A Kanetsky, Colin B Begg, Kathleen Conway, Marianne Berwick.   

Abstract

In this issue, Hacker and colleagues provide further evidence that molecular subtypes of malignant melanoma may develop along divergent pathways. The authors did not find an association between somatic BRAF-mutant melanoma and germline melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in light of previous studies demonstrating strong associations.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20010862      PMCID： PMC2950747          DOI： 10.1038/jid.2009.332

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  15 in total

1.  Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk.

Authors:  Frank L Meyskens; Patrick J Farmer; Hoda Anton-Culver
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

2.  NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

Authors:  Esther Edlundh-Rose; Suzanne Egyházi; Katarina Omholt; Eva Månsson-Brahme; Anton Platz; Johan Hansson; Joakim Lundeberg
Journal:  Melanoma Res       Date:  2006-12       Impact factor: 3.599

3.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

4.  MC1R germline variants confer risk for BRAF-mutant melanoma.

Authors:  Maria Teresa Landi; Jürgen Bauer; Ruth M Pfeiffer; David E Elder; Benjamin Hulley; Paola Minghetti; Donato Calista; Peter A Kanetsky; Daniel Pinkel; Boris C Bastian
Journal:  Science       Date:  2006-06-29       Impact factor: 47.728

5.  Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.

Authors:  Wendy Liu; John W Kelly; Melanie Trivett; William K Murray; John P Dowling; Rory Wolfe; Graham Mason; Jill Magee; Christopher Angel; Alexander Dobrovic; Grant A McArthur
Journal:  J Invest Dermatol       Date:  2006-12-07       Impact factor: 8.551

6.  BRAF and NRAS mutations in melanoma and melanocytic nevi.

Authors:  Jenny N Poynter; James T Elder; Douglas R Fullen; Rajan P Nair; Maria S Soengas; Timothy M Johnson; Bruce Redman; Nancy E Thomas; Stephen B Gruber
Journal:  Melanoma Res       Date:  2006-08       Impact factor: 3.599

Review 7.  Amelanotic metastatic melanoma in a patient with oculocutaneous albinism.

Authors:  H Ihn; K Nakamura; M Abe; M Furue; K Takehara; H Nakagawa; Y Ishibashi
Journal:  J Am Acad Dermatol       Date:  1993-05       Impact factor: 11.527

Review 8.  The melanocortin 1 receptor and the UV response of human melanocytes--a shift in paradigm.

Authors:  Zalfa A Abdel-Malek; James Knittel; Ana Luisa Kadekaro; Viki B Swope; Renny Starner
Journal:  Photochem Photobiol       Date:  2008-02-11       Impact factor: 3.421

9.  MC1R variants increase risk of melanomas harboring BRAF mutations.

Authors:  Maria Concetta Fargnoli; Maria Concetia Fargnoli; Kris Pike; Ruth M Pfeiffer; Shirley Tsang; Ester Rozenblum; David J Munroe; Yelena Golubeva; Donato Calista; Stefania Seidenari; Daniela Massi; Paolo Carli; Juergen Bauer; David E Elder; Boris C Bastian; Ketty Peris; Maria T Landi
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

10.  Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Audrey Alexander; Robert C Millikan; Pamela A Groben; Honglin Hao; Dawn Tolbert; Marianne Berwick; Klaus Busam; Colin B Begg; Dianne Mattingly; David W Ollila; Chiu Kit Tse; Amanda Hummer; Julia Lee-Taylor; Kathleen Conway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-05       Impact factor: 4.254
View more
  3 in total

1.  Genetic and morphologic features for melanoma classification.

Authors:  Sigrid M C Broekaert; Ritu Roy; Ichiro Okamoto; Joost van den Oord; Jürgen Bauer; Claus Garbe; Raymond L Barnhill; Klaus J Busam; Alistair J Cochran; Martin G Cook; David E Elder; Stanley W McCarthy; Martin C Mihm; Dirk Schadendorf; Richard A Scolyer; Alan Spatz; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2010-12       Impact factor: 4.693

2.  Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Peter A Kanetsky; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Li Luo; Irene Orlow; Anne S Reiner; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Eloise A Parrish; Honglin Hao; David C Gibbs; Jill S Frank; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2017-08-24       Impact factor: 8.551

3.  Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population.

Authors:  J A Puig-Butillé; C Carrera; R Kumar; Z Garcia-Casado; C Badenas; P Aguilera; J Malvehy; E Nagore; S Puig
Journal:  Br J Dermatol       Date:  2013-10       Impact factor: 9.302
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.